Birdwatch Note
2024-03-20 13:57:14 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Falso: Ninguna organizaciĆ³n ha aprobado el uso de ivermectina en pacientes con COVID. https://www.mdsaude.com/es/prospecto/ivermectina-para-que-sirve/ https://www.argentina.gob.ar/sites/default/files/informe-rapido-covid-19-n04-ivermectina-25-02-22.pdf
Written by 574A09B8332EA43C5D736223D2AF1026DB5941ADE8681579E8708A4B827EDBD3
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1770438251800567834
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1770449522411413886
- noteId - 1770449522411413886
- participantId -
- noteAuthorParticipantId - 574A09B8332EA43C5D736223D2AF1026DB5941ADE8681579E8708A4B827EDBD3 Participant Details
- createdAtMillis - 1710943034161
- tweetId - 1770438251800567834
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Falso: Ninguna organizaciĆ³n ha aprobado el uso de ivermectina en pacientes con COVID. https://www.mdsaude.com/es/prospecto/ivermectina-para-que-sirve/ https://www.argentina.gob.ar/sites/default/files/informe-rapido-covid-19-n04-ivermectina-25-02-22.pdf
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-20 13:57:14 UTC (1710943034161) |
2024-03-20 18:45:41 UTC (1710960341247) |
CURRENTLY_RATED_HELPFUL | 2024-03-21 01:30:52 UTC (1710984652589) |
CURRENTLY_RATED_HELPFUL | 2024-03-20 18:45:41 UTC (1710960341247) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-20 19:02:24 -0500 | Rating Details | |
2024-03-20 18:57:54 -0500 | Rating Details | |
2024-03-20 18:45:18 -0500 | Rating Details | |
2024-03-20 18:20:51 -0500 | Rating Details | |
2024-03-20 17:28:26 -0500 | Rating Details | |
2024-03-20 16:51:00 -0500 | Rating Details | |
2024-03-20 16:21:00 -0500 | Rating Details | |
2024-03-20 15:22:41 -0500 | Rating Details | |
2024-03-20 15:18:18 -0500 | Rating Details | |
2024-03-20 14:23:46 -0500 | Rating Details | |
2024-03-20 14:14:42 -0500 | Rating Details | |
2024-03-20 13:49:15 -0500 | Rating Details | |
2024-03-20 13:33:42 -0500 | Rating Details | |
2024-03-20 13:25:20 -0500 | Rating Details | |
2024-03-20 13:18:30 -0500 | Rating Details | |
2024-03-20 13:00:54 -0500 | Rating Details | |
2024-03-20 12:51:19 -0500 | Rating Details | |
2024-03-20 12:48:35 -0500 | Rating Details | |
2024-03-20 12:48:01 -0500 | Rating Details | |
2024-03-20 12:40:38 -0500 | Rating Details | |
2024-03-20 11:14:30 -0500 | Rating Details | |
2024-03-20 11:03:39 -0500 | Rating Details | |
2024-03-20 10:49:34 -0500 | Rating Details | |
2024-03-20 10:29:34 -0500 | Rating Details | |
2024-03-20 10:24:46 -0500 | Rating Details | |
2024-03-20 10:15:49 -0500 | Rating Details | |
2024-03-20 09:59:26 -0500 | Rating Details | |
2024-03-20 09:04:39 -0500 | Rating Details | |
2024-03-21 15:23:06 -0500 | Rating Details | |
2024-03-21 10:29:15 -0500 | Rating Details | |
2024-03-21 07:31:39 -0500 | Rating Details | |
2024-03-21 06:21:54 -0500 | Rating Details | |
2024-03-21 04:52:38 -0500 | Rating Details | |
2024-03-21 01:50:10 -0500 | Rating Details | |
2024-03-21 00:47:47 -0500 | Rating Details | |
2024-03-20 22:35:04 -0500 | Rating Details | |
2024-03-20 19:40:10 -0500 | Rating Details | |
2024-03-20 19:10:52 -0500 | Rating Details | |
2024-03-21 23:10:39 -0500 | Rating Details | |
2024-03-21 13:33:17 -0500 | Rating Details | |
2024-03-21 12:11:57 -0500 | Rating Details | |
2024-03-21 12:03:39 -0500 | Rating Details | |
2024-03-21 10:27:38 -0500 | Rating Details | |
2024-03-21 08:23:10 -0500 | Rating Details | |
2024-03-21 07:29:15 -0500 | Rating Details | |
2024-03-21 06:19:59 -0500 | Rating Details | |
2024-03-21 06:13:10 -0500 | Rating Details | |
2024-03-21 05:40:29 -0500 | Rating Details | |
2024-03-21 05:32:58 -0500 | Rating Details | |
2024-03-21 01:27:46 -0500 | Rating Details | |
2024-03-20 22:41:52 -0500 | Rating Details | |
2024-03-20 20:51:08 -0500 | Rating Details | |
2024-03-20 20:18:10 -0500 | Rating Details | |
2024-03-20 20:15:43 -0500 | Rating Details | |
2024-03-20 20:12:20 -0500 | Rating Details | |
2024-03-20 18:57:46 -0500 | Rating Details | |
2024-03-20 18:55:23 -0500 | Rating Details | |
2024-03-20 17:00:29 -0500 | Rating Details | |
2024-03-20 16:34:16 -0500 | Rating Details | |
2024-03-20 14:50:13 -0500 | Rating Details | |
2024-03-20 14:38:48 -0500 | Rating Details | |
2024-03-20 14:25:18 -0500 | Rating Details | |
2024-03-20 13:37:41 -0500 | Rating Details | |
2024-03-20 11:56:29 -0500 | Rating Details | |
2024-03-20 11:31:09 -0500 | Rating Details | |
2024-03-20 11:26:18 -0500 | Rating Details | |
2024-03-20 11:04:20 -0500 | Rating Details | |
2024-03-20 10:55:30 -0500 | Rating Details | |
2024-03-20 10:38:56 -0500 | Rating Details | |
2024-03-20 10:31:35 -0500 | Rating Details | |
2024-03-20 10:30:28 -0500 | Rating Details | |
2024-03-20 10:28:17 -0500 | Rating Details | |
2024-03-20 10:18:28 -0500 | Rating Details | |
2024-03-20 10:03:24 -0500 | Rating Details | |
2024-03-20 09:45:20 -0500 | Rating Details | |
2024-03-20 09:27:47 -0500 | Rating Details | |
2024-03-20 09:20:33 -0500 | Rating Details | |
2024-03-20 09:05:23 -0500 | Rating Details | |
2024-03-21 10:34:27 -0500 | Rating Details | |
2024-03-21 05:19:07 -0500 | Rating Details | |
2024-03-21 00:03:08 -0500 | Rating Details | |
2024-03-20 22:39:57 -0500 | Rating Details | |
2024-03-20 20:17:01 -0500 | Rating Details | |
2024-03-20 18:53:53 -0500 | Rating Details | |
2024-03-20 17:24:54 -0500 | Rating Details | |
2024-03-20 17:08:51 -0500 | Rating Details | |
2024-03-20 16:51:51 -0500 | Rating Details | |
2024-03-20 16:50:42 -0500 | Rating Details | |
2024-03-20 16:41:32 -0500 | Rating Details | |
2024-03-20 16:27:49 -0500 | Rating Details | |
2024-03-20 16:16:10 -0500 | Rating Details | |
2024-03-20 15:32:18 -0500 | Rating Details | |
2024-03-20 15:06:15 -0500 | Rating Details | |
2024-03-20 15:05:39 -0500 | Rating Details | |
2024-03-20 13:56:28 -0500 | Rating Details | |
2024-03-20 13:48:26 -0500 | Rating Details | |
2024-03-20 13:48:14 -0500 | Rating Details | |
2024-03-20 13:47:46 -0500 | Rating Details | |
2024-03-20 13:39:42 -0500 | Rating Details | |
2024-03-20 13:01:11 -0500 | Rating Details | |
2024-03-20 12:57:12 -0500 | Rating Details | |
2024-03-20 12:44:03 -0500 | Rating Details | |
2024-03-20 12:41:40 -0500 | Rating Details | |
2024-03-20 12:28:55 -0500 | Rating Details | |
2024-03-20 12:10:47 -0500 | Rating Details | |
2024-03-20 11:32:02 -0500 | Rating Details | |
2024-03-20 11:12:41 -0500 | Rating Details | |
2024-03-20 10:57:25 -0500 | Rating Details | |
2024-03-20 10:39:27 -0500 | Rating Details | |
2024-03-20 10:21:40 -0500 | Rating Details | |
2024-03-20 10:14:32 -0500 | Rating Details | |
2024-03-20 09:51:15 -0500 | Rating Details | |
2024-03-20 09:29:09 -0500 | Rating Details | |
2024-03-20 09:24:45 -0500 | Rating Details |